Clinical Trials
3 trialsNCT03276832 2026-03-19
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT07210775 2026-03-04
Topical Imiquimod Treatment of Oral Dysplasia
University of Southern California
Phase 1/2 Recruiting
NCT03534947 2025-12-16
SONIB
Melanoma Institute Australia
Phase 2 Completed